ASX - By Stock
|
PER |
Re:
Ann: Percheron Therapeutics Limited Corporate Presentation
|
|
Uboy
|
148 |
52K |
17 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
148
|
52K
|
17
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron Therapeutics Limited Corporate Presentation
|
|
Uboy
|
148 |
52K |
26 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
148
|
52K
|
26
|
|
ASX - By Stock
|
PER |
Re:
Open House 09/SEP/2024
|
|
Uboy
|
63 |
17K |
7 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
63
|
17K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Open House 09/SEP/2024
|
|
Uboy
|
63 |
17K |
6 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
63
|
17K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Open House 09/SEP/2024
|
|
Uboy
|
63 |
17K |
27 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
63
|
17K
|
27
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Shows Preclinical Activity in Autoimmune Epilepsy
|
|
Uboy
|
47 |
14K |
2 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
47
|
14K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Shows Preclinical Activity in Autoimmune Epilepsy
|
|
Uboy
|
47 |
14K |
16 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
47
|
14K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Shows Preclinical Activity in Autoimmune Epilepsy
|
|
Uboy
|
47 |
14K |
22 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
47
|
14K
|
22
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Annual Report
|
|
Uboy
|
74 |
22K |
9 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
74
|
22K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Uboy
|
238 |
69K |
16 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
238
|
69K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Uboy
|
238 |
69K |
29 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
238
|
69K
|
29
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Uboy
|
1.3K |
353K |
24 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.3K
|
353K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Uboy
|
157 |
39K |
12 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
39K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Uboy
|
238 |
69K |
24 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
238
|
69K
|
24
|
|
ASX - By Stock
|
IXR |
Re:
Ann: Ionic Technologies Starts Continuous Magnet REO Production
|
|
Uboy
|
24 |
12K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
24
|
12K
|
0
|
|
ASX - By Stock
|
DUB |
Re:
Dubber.Dubber.Do.
|
|
Uboy
|
8.3K |
3.9M |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
8.3K
|
3.9M
|
3
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
366 |
121K |
10 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
366
|
121K
|
10
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
366 |
121K |
15 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
366
|
121K
|
15
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
366 |
121K |
22 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
366
|
121K
|
22
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
366 |
121K |
21 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
366
|
121K
|
21
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Uboy
|
1.3K |
353K |
16 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.3K
|
353K
|
16
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Uboy
|
366 |
121K |
19 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
366
|
121K
|
19
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Registered Office and Principal Place of Business
|
|
Uboy
|
4 |
1.7K |
8 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
4
|
1.7K
|
8
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
41K |
1 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
41K
|
1
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
41K |
8 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
41K
|
8
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
41K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
41K
|
1
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
41K |
12 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
161
|
41K
|
12
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Uboy
|
161 |
41K |
13 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
161
|
41K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual General Meeting Presentation
|
|
Uboy
|
81 |
21K |
18 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
81
|
21K
|
18
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to participate in upcoming investor conferences
|
|
Uboy
|
15 |
4.5K |
10 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
15
|
4.5K
|
10
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
7 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
25 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
25
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
11 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
11
|
|
ASX - By Stock
|
NXL |
Re:
Ann: Director Retirement
|
|
Uboy
|
33 |
10K |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
33
|
10K
|
3
|
|
ASX - By Stock
|
NXL |
Re:
Ann: Director Retirement
|
|
Uboy
|
33 |
10K |
2 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
NXL |
Re:
NUIX vs ASIC
|
|
Uboy
|
17 |
6.1K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
17
|
6.1K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Uboy
|
3.5K |
1.0M |
20 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
20
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
51K |
15 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
190
|
51K
|
15
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
51K |
18 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
190
|
51K
|
18
|
|
ASX - By Stock
|
FFX |
Re:
General discussion
|
|
Uboy
|
10K |
3.4M |
25 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
10K
|
3.4M
|
25
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
51K |
7 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
190
|
51K
|
7
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Uboy
|
190 |
51K |
10 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
190
|
51K
|
10
|
|
ASX - By Stock
|
WHC |
Re:
Climate Change
|
|
Uboy
|
1.0K |
227K |
3 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.0K
|
227K
|
3
|
|
ASX - By Stock
|
WHC |
Re:
Climate Change
|
|
Uboy
|
1.0K |
227K |
12 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
1.0K
|
227K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Other indications
|
|
Uboy
|
64 |
17K |
24 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
64
|
17K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive new DMD Combination Therapy Data in mdx mice
|
|
Uboy
|
66 |
19K |
22 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
66
|
19K
|
22
|
|
ASX - By Stock
|
NXL |
Re:
Ann: FY23 Preliminary Results Update
|
|
Uboy
|
70 |
23K |
0 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Intention to launch Share Purchase Plan
|
|
Uboy
|
75 |
22K |
14 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
75
|
22K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: Institutional Placement and proposed Share Purchase Plan SPP
|
|
Uboy
|
71 |
19K |
3 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
71
|
19K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Uboy
|
158 |
46K |
6 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
46K
|
6
|
|